Claes Wahlestedt, M.D., Ph.D.
Affiliations: | University of Miami School of Medicine | University of Miami School of Medicine, Miami, FL, United States |
Area:
molecular neuroscienceGoogle:
"Claes Wahlestedt"Mean distance: 106866
Collaborators
Sign in to add collaborator| Claude-Henry Volmar | collaborator | 2011- | University of Miami Miller School of Medicine |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lalwani RC, Volmar CH, Wahlestedt C, et al. (2023) Contextualizing the Role of Osteopontin in the Inflammatory Responses of Alzheimer's Disease. Biomedicines. 11 |
| Dennison J, Mendez A, Szeto A, et al. (2023) Low-Dose Chidamide Treatment Displays Sex-Specific Differences in the 3xTg-AD Mouse. Biomolecules. 13 |
| McCartan R, Khorkova O, Volmar CH, et al. (2023) Nucleic acid-based therapeutics for the treatment of central nervous system disorders. Frontiers in Genetics. 14: 1250276 |
| Khorkova O, Stahl J, Joji A, et al. (2023) Long non-coding RNA-targeting therapeutics: discovery and development update. Expert Opinion On Drug Discovery. 1-19 |
| Stokes T, Cen HH, Kapranov P, et al. (2023) Transcriptomics for Clinical and Experimental Biology Research: Hang on a Seq. Advanced Genetics (Hoboken, N.J.). 4: 2200024 |
| Khorkova O, Stahl J, Joji A, et al. (2023) Amplifying gene expression with RNA-targeted therapeutics. Nature Reviews. Drug Discovery |
| Ricciardi NR, Modarresi F, Lohse I, et al. (2023) Investigating the Synergistic Potential of Low-Dose HDAC3 Inhibition and Radiotherapy in Alzheimer's Disease Models. Molecular Neurobiology |
| Khorkova O, Stahl J, Joji A, et al. (2022) Natural antisense transcripts as drug targets. Frontiers in Molecular Biosciences. 9: 978375 |
| Dennison JL, Al-Ali H, Volmar CH, et al. (2022) Functional Drug Screening of Small Molecule Inhibitors of Epigenetic Modifiers in Refractory AML Patients. Cancers. 14 |
| Kemper C, Benham D, Brothers S, et al. (2022) Safety and pharmacokinetics of a highly bioavailable resveratrol preparation (JOTROL ). Aaps Open. 8: 11 |